On Monday November 20th, Merck (NYSE: MRK) announced the second biopharmaceutical cohort of the Merck Digital Sciences Studio (MDS Studio or MDSS), a collaboration between Merck, Merck Global Health Innovation Fund, Northpond Ventures, McKesson Ventures, Microsoft for Startups, and the New Jersey Innovation Institute, a New Jersey Institute of Technology (NJIT) subsidiary. The 10-month startup accelerator program, with direct investments from Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, empowers members and enables the generation of innovative digital technologies for drug discovery and development through hands-on mentorship, connection opportunities with industry-leading partners, and training in an active entrepreneurial setting. Through the accelerator program, these startups will have access to workshops, coaching, office space, and Microsoft for Startups Founders Hub resources, including up to $150,000 Azure Cloud computing credits. The collaborative startup cohort will focus on important and disruptive bio-technical approaches in artificial intelligence (AI) and machine learning (ML), with expertise and tools from clinical scientists to continue Merck’s purpose to use the power of leading-edge science to save and improve lives. ## Latest Updates from dannce.ai ### June 23, 2025 **Dannce.ai Appoints Industry Leader to Board of Directors - Raymond Sanchez** Preeminent CNS expert Ray Sanchez joins Dannce.ai's Board of Directors Read more: [Link](/content/news/dannce-ai-appoints-industry-leader-to-board-of-directors---raymond-sanchez/index.html) ### December 3, 2024 **Dannce.ai CEO Rob Baldoni named Forbes 30 Under 30 in Healthcare** We’re proud to announce that our CEO, Rob Baldoni, was included in the Forbes 30 under 30 list this year! Congratulations to all the other honorees. Read more: [Link](/content/news/dannce-ai-ceo-rob-baldoni-named-forbes-30-under-30-in-healthcare/index.html) ### November 21, 2024 **Dannce.ai Announces Close of $2.6M Pre-Seed Financing** Round led by LDV Capital, following initial investment from Glasswing Ventures, with participation from The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio Read more: [Link](/content/news/dannce-ai-announces-close-of-2-6m-pre-seed-financing/index.html) ### September 25, 2024 **BostInno: Meet BostInno’s 25 under 25 for 2024** dannce.ai CEO Rob Baldoni was featured in BostInno's 25 under 25 for 2024 Read more: [Link](/content/news/bostinno-meet-bostinnos-25-under-25-for-2024/index.html) ### April 19, 2021 **Learning to DANNCE by Duke AI Health** A group of neuroscientists and machine learning experts are developing new ways to analyze animal movement and behavior to gain insights into the inner workings of the nervous system. Read more: [Link](/content/news/learning-to-dannce/index.html) ### February 10, 2024 **Dannce.ai Wins 2024 Future of Capitalism Seed Funding Investment Competition** We won! We are so excited to work with the team on building our company in a way that aligns with our ethics. Read more: [Link](/content/news/dannce-ai-wins-2024-future-of-capitalism-seed-funding-investment-competition/index.html) ### July 14, 2025 **Dannce.ai Welcomes Dr. Richard Trosch as a Clinical Advisor** Movement Disorder Specialist Richard Trosch joins Dannce.ai as an Advisor Read more: [Link](/content/news/dannce-ai-richard-trosch/index.html) ## Explore How AI Can Transform Neurological Care Learn how dannce.ai can accelerate your clinical trials or improve patient outcomes with cutting-edge AI technology.